Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial.

Diaz RS, Shytaj IL, Giron LB, Obermaier B, Della Libera E Jr, Galinskas J, Dias D, Hunter J, Janini M, Gosuen G, Ferreira PA, Sucupira MC, Maricato J, Fackler O, Lusic M, Savarino A; SPARC Working Group.

Int J Antimicrob Agents. 2019 Nov;54(5):592-600. doi: 10.1016/j.ijantimicag.2019.08.001. Epub 2019 Aug 5.

PMID:
31394172
2.

Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy.

Giron LB, Tenore SB, Janini LMR, Sucupira MCA, Diaz RS.

PLoS One. 2019 Jun 17;14(6):e0217502. doi: 10.1371/journal.pone.0217502. eCollection 2019.

3.

Modulation of epigenetic factors during the early stages of HIV-1 infection in CD4+ T cells in vitro.

Nunes JM, Furtado MN, de Morais Nunes ER, Sucupira MCA, Diaz RS, Janini LMR.

Virology. 2018 Oct;523:41-51. doi: 10.1016/j.virol.2018.07.026. Epub 2018 Aug 2.

PMID:
30077875
4.

Insights about minority HIV-1 strains in transmitted drug resistance mutation dynamics and disease progression.

Leda AR, Hunter J, Oliveira UC, Azevedo IJ, Sucupira MCA, Diaz RS.

J Antimicrob Chemother. 2018 Jul 1;73(7):1930-1934. doi: 10.1093/jac/dky132.

PMID:
29684141
5.

Impact of antiretroviral resistance and virological failure on HIV-1 informational entropy.

Lima ENC, Piqueira JRC, Camargo M, Galinskas J, Sucupira MC, Diaz RS.

J Antimicrob Chemother. 2018 Apr 1;73(4):1054-1059. doi: 10.1093/jac/dkx508.

PMID:
29373694
6.

Thalidomide is Associated With Increased T Cell Activation and Inflammation in Antiretroviral-naive HIV-infected Individuals in a Randomised Clinical Trial of Efficacy and Safety.

Vergara TRC, Samer S, Santos-Oliveira JR, Giron LB, Arif MS, Silva-Freitas ML, Cherman LA, Treitsman MS, Chebabo A, Sucupira MCA, Da-Cruz AM, Diaz RS; SPARC Working Group.

EBioMedicine. 2017 Sep;23:59-67. doi: 10.1016/j.ebiom.2017.08.007. Epub 2017 Aug 12.

7.

Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.

Arif MS, Hunter J, Léda AR, Zukurov JPL, Samer S, Camargo M, Galinskas J, Kallás EG, Komninakis SV, Janini LM, Sucupira MC, Diaz RS.

J Virol. 2017 Sep 12;91(19). pii: e00793-17. doi: 10.1128/JVI.00793-17. Print 2017 Oct 1.

8.

Evidence of Noncompetent HIV after Ex Vivo Purging Among ART-Suppressed Individuals.

Samer S, Namiyama G, Oshiro T, Arif MS, Cardoso da Silva W, Sucupira MCA, Janini LM, Diaz RS.

AIDS Res Hum Retroviruses. 2017 Oct;33(10):993-994. doi: 10.1089/aid.2017.0036. Epub 2017 Jun 20. No abstract available.

PMID:
28632400
9.

Uniquely altered transcripts are associated with immune preservation in HIV infection.

Zanoni M, Aventurato ÍK, Hunter J, Sucupira MC, Diaz RS.

PLoS One. 2017 Mar 28;12(3):e0169868. doi: 10.1371/journal.pone.0169868. eCollection 2017.

10.

Correction: Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment.

Scarpellini B, Zanoni M, Sucupira MC, Truong HM, Janini LM, da Silva ID, Diaz RS.

PLoS One. 2017 Feb 24;12(2):e0173164. doi: 10.1371/journal.pone.0173164. eCollection 2017.

11.

Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment.

Scarpellini B, Zanoni M, Sucupira MC, Truong HM, Janini LM, Segurado ID, Diaz RS.

PLoS One. 2016 Dec 12;11(12):e0161920. doi: 10.1371/journal.pone.0161920. eCollection 2016. Erratum in: PLoS One. 2017 Feb 24;12 (2):e0173164. Scarpelini, Bruno [corrected to Scapellini, Bruno].

12.

Foreign body-induced changes in the reticular contraction pattern of sheep observed with M-mode ultrasonography.

Morgado AA, Sucupira MC, Nunes GR, Hagen SC.

Open Vet J. 2015;5(1):34-7. Epub 2015 Apr 16.

13.

The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use.

Diaz RS, Inocêncio LA, Sucupira MC, Pereira AA, Hunter J, Ferreira JE, Araújo LV, Souza DF, Sabino EC.

PLoS One. 2015 Oct 28;10(10):e0139677. doi: 10.1371/journal.pone.0139677. eCollection 2015.

14.

High prevalence and incidence of HIV-1 in a counseling and testing center in the city of Itajaí, Brazil.

Grinberg G, Giron LB, Knoll RK, Galinskas J, Camargo M, Arif MS, Samer S, Janini LM, Sucupira MC, Diaz RS.

Braz J Infect Dis. 2015 Nov-Dec;19(6):631-5. doi: 10.1016/j.bjid.2015.08.001. Epub 2015 Sep 9.

15.

Prevalence of transmitted HIV-1 antiretroviral resistance among patients initiating antiretroviral therapy in Brazil: a surveillance study using dried blood spots.

de Moraes Soares CM, Vergara TR, Brites C, Brito JD, Grinberg G, Caseiro MM, Correa C, Suffert TA, Pereira FR, Camargo M, Janini LM, Komninakis S, Sucupira MC, Diaz RS.

J Int AIDS Soc. 2014 Sep 22;17:19042. doi: 10.7448/IAS.17.1.19042. eCollection 2014.

16.

In vivo HIV-1 hypermutation and viral loads among antiretroviral-naive Brazilian patients.

de Lima-Stein ML, Alkmim WT, Bizinoto MC, Lopez LF, Burattini MN, Maricato JT, Giron L, Sucupira MC, Diaz RS, Janini LM.

AIDS Res Hum Retroviruses. 2014 Sep;30(9):867-80. doi: 10.1089/AID.2013.0241. Epub 2014 Aug 25.

17.

High rates of human immunodeficiency virus type 1 mutational profiles by single-genome amplification after 48-hour propagation in peripheral blood mononuclear cells at different levels of cell activation.

Russo CT, Alkmim W, Munerato P, Zukurov J, Maricato JT, Sucupira MC, Diaz RS, Janini LM.

Intervirology. 2014;57(5):277-88. doi: 10.1159/000362415. Epub 2014 Jun 28.

18.

Homogenous HIV-1 subtype B quasispecies in Brazilian men and women recently infected via heterosexual transmission.

Gouveia NL, Camargo M, Caseiro MM, Janini LM, Sucupira MC, Diaz RS.

Virus Genes. 2014 Jun;48(3):421-8. doi: 10.1007/s11262-014-1048-x. Epub 2014 Feb 14.

PMID:
24526349
19.

Analysis of HIV-1 protease gene reveals frequent multiple infections followed by recombination among drug treated individuals living in São Paulo and Santos, Brazil.

Nunes ER, Zukurov JP, Maricato JT, Sucupira MC, Diaz RS, Janini LM.

PLoS One. 2014 Jan 3;9(1):e84066. doi: 10.1371/journal.pone.0084066. eCollection 2014.

20.

Short communication: HIV type 1 subtype BF leads to faster CD4+ T cell loss compared to subtype B.

Tarosso LF, Sanabani SS, Ribeiro SP, Sauer MM, Tomiyama HI, Sucupira MC, Diaz RS, Sabino EC, Kalil J, Kallas EG.

AIDS Res Hum Retroviruses. 2014 Feb;30(2):190-4. doi: 10.1089/AID.2012.0243. Epub 2013 Sep 6.

PMID:
23906381
21.

Phenotypic susceptibility to antiretrovirals among clades C, F, and B/F recombinant antiretroviral-naive HIV type 1 strains.

Sucupira MC, Munerato P, Silveira J, Santos AF, Janini LM, Soares MA, Diaz RS.

AIDS Res Hum Retroviruses. 2013 Jun;29(6):880-6. doi: 10.1089/AID.2012.0259. Epub 2013 Mar 8.

PMID:
23398474
22.

Intermediate levels of transmitted antiretroviral drug resistance in Midwestern Brazil.

Pfrimer IA, Bizinoto MC, Brandão NA, Camargo M, Sucupira MC, Janini LM, Diaz RS.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):205-6. doi: 10.1089/AID.2012.0012. Epub 2012 Oct 9. No abstract available.

PMID:
22978276
23.

Faster HIV-1 disease progression among Brazilian individuals recently infected with CXCR4-utilizing strains.

Sucupira MC, Sanabani S, Cortes RM, Giret MT, Tomiyama H, Sauer MM, Sabino EC, Janini LM, Kallas EG, Diaz RS.

PLoS One. 2012;7(1):e30292. doi: 10.1371/journal.pone.0030292. Epub 2012 Jan 26.

24.

Comparative effectiveness of dried-plasma hepatitis B virus viral load (VL) testing in three different VL commercial platforms using ViveST for sample collection.

Zanoni M, Giron LB, Vilhena C, Sucupira MC, Lloyd RM Jr, Diaz RS.

J Clin Microbiol. 2012 Jan;50(1):145-7. doi: 10.1128/JCM.01016-11. Epub 2011 Oct 19.

25.

Prevalence and factors associated with HSV-2 and hepatitis B infections among truck drivers crossing the southern Brazilian border.

Pinho AA, Chinaglia M, Lippman SA, Reingold A, Diaz RS, Sucupira MC, Page K, Díaz J.

Sex Transm Infect. 2011 Dec;87(7):553-9. doi: 10.1136/sextrans-2011-050186. Epub 2011 Oct 3.

26.

Intracellular reactive oxygen species production by polymorphonuclear leukocytes in bovine leukemia virus-infected dairy cows.

Souza FN, Blagitz MG, Latorre AO, Ramos Sanchez EM, Batista CF, Weigel RA, Renno FP, Sucupira MC, Della Libera AM.

J Vet Med Sci. 2012 Feb;74(2):221-5. Epub 2011 Sep 22.

27.

The Brazilian network for HIV-1 genotyping external quality control assurance programme.

Souza DC, Sucupira MC, Brindeiro RM, Fernandez JC, Sabino EC, Inocencio LA, Diaz RS.

J Int AIDS Soc. 2011 Sep 21;14:45. doi: 10.1186/1758-2652-14-45.

28.

Prevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, Brazil.

Giret MT, Miraglia JL, Sucupira MC, Nishiya A, Levi JE, Diaz RS, Sabino EC, Kallas EG.

PLoS One. 2011 Apr 5;6(4):e18407. doi: 10.1371/journal.pone.0018407.

29.

Differential persistence of transmitted HIV-1 drug resistance mutation classes.

Jain V, Sucupira MC, Bacchetti P, Hartogensis W, Diaz RS, Kallas EG, Janini LM, Liegler T, Pilcher CD, Grant RM, Cortes R, Deeks SG, Hecht FM.

J Infect Dis. 2011 Apr 15;203(8):1174-81. doi: 10.1093/infdis/jiq167.

30.

HIV-1 resistance testing influences treatment decision-making.

Diaz RS, Sucupira MC, Vergara TR, Brites C, Bianco RD, Bonasser Filho F, Colares GK, Portela E, Cherman LA, Barcelos NT, Tupinambas U, Turcato G Jr, Allamasey L, Bacheler L, Tuohy M; Brazilian Network Reference Physicians Working Group.

Braz J Infect Dis. 2010 Sep-Oct;14(5):489-94.

31.

The association between primary antiretroviral resistance and HAART virologic failure in a developing set.

Gagliani LH, Alkmim Maia WT, Sá-Filho D, Janini LM, Sucupira MC, Caseiro MM, Diaz RS.

AIDS Res Hum Retroviruses. 2011 Mar;27(3):251-6. doi: 10.1089/aid.2010.0150. Epub 2010 Oct 26.

PMID:
20977353
32.

Comparative effectiveness of dried plasma HIV-1 viral load testing in Brazil using ViveST for sample collection.

Zanoni M, Cortes R, Diaz RS, Sucupira MC, Ferreira D, Inocencio LA, Vilhena C, Loveday C, Lloyd RM Jr, Holodniy M.

J Clin Virol. 2010 Dec;49(4):245-8. doi: 10.1016/j.jcv.2010.08.017. Epub 2010 Sep 29.

PMID:
20880740
33.

The detection of in vivo and in vitro HIV type 1 B/F profiles in Brazil using a real-time PCR assay for five HIV type 1 genomic regions.

Teixeira D, Munerato P, Komninakis SC, Fusuma EE, Janini LM, Sucupira MC, Diaz RS.

AIDS Res Hum Retroviruses. 2010 Sep;26(9):981-90. doi: 10.1089/aid.2010.0023.

PMID:
20707640
34.

HIV type 1 antiretroviral resistance mutations in subtypes B, C, and F in the City of São Paulo, Brazil.

Munerato P, Sucupira MC, Oliveros MP, Janini LM, de Souza DF, Pereira AA, Inocencio LA, Diaz RS.

AIDS Res Hum Retroviruses. 2010 Mar;26(3):265-73. doi: 10.1089/aid.2009.0288.

PMID:
20210652
35.

Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women.

Lippman SA, Sucupira MC, Jones HE, Luppi CG, Palefsky J, van de Wijgert JH, Oliveira RL, Diaz RS.

Int J STD AIDS. 2010 Feb;21(2):105-9. doi: 10.1258/ijsa.2009.008436. Erratum in: Int J STD AIDS. 2010 Mar;21(3):227.

36.

Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV.

Inocencio LA, Pereira AA, Sucupira MC, Fernandez JC, Jorge CP, Souza DF, Fink HT, Diaz RS, Becker IM, Suffert TA, Arruda MB, Macedo O, Simão MB, Tanuri A.

J Int AIDS Soc. 2009 Sep 18;12:20. doi: 10.1186/1758-2652-12-20.

37.

Estimating HIV-1 incidence using the serologic testing algorithm for recent HIV infections at HIV counseling and testing centers in the city of São Paulo, Brazil.

Bassichetto KC, Bergamaschi DP, Veras MA, Sucupira MC, Mesquita F, Diaz RS.

Braz J Infect Dis. 2009 Feb;13(1):9-12.

PMID:
19578623
38.

Molecular and structural characterization of HIV-1 subtype B Brazilian isolates with GWGR tetramer at the tip of the V3-loop.

Leal E, Silva WP, Sucupira MC, Janini LM, Diaz RS.

Virology. 2008 Nov 25;381(2):222-9. doi: 10.1016/j.virol.2008.08.029. Epub 2008 Sep 23.

39.

Selective regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic.

Diaz RS, Leal E, Sanabani S, Sucupira MC, Tanuri A, Sabino EC, Janini LM.

Virology. 2008 Nov 25;381(2):184-93. doi: 10.1016/j.virol.2008.08.014. Epub 2008 Sep 21.

40.

Emergence of resistance mutations preceding virologic failure in patients receiving antiretroviral therapy.

Diaz RS, Accetturi CA, Sucupira MC.

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):111-3. doi: 10.1097/QAI.0b013e31817bec51. No abstract available.

PMID:
18725808
41.

Profiling resistance-related mutations in the protease region of the pol gene: single genome sequencing of HIV in plasma and peripheral blood mononuclear cells.

Guimarães AP, Sa-Filho DJ, Sucupira MC, Janini LM, Diaz RS.

AIDS Res Hum Retroviruses. 2008 Jul;24(7):969-71. doi: 10.1089/aid.2008.0020.

PMID:
18593345
42.

Similar efficacy of lopinavir/ritonavir-containing regimens among clades B and F HIV-1-Infected individuals in Brazil.

Diaz RS, Vasconcelos L, Hayden RL, Tenore S, Turcato G Jr, Palácios R, Sucupira MC.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):399-401. No abstract available.

PMID:
18398975
43.

Cerebrospinal fluid viral load quantification in an HIV-1-infected pediatric group.

Rocha CM, Machado DM, Sucupira MC, Succi RC.

J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):508-9. No abstract available.

PMID:
17993858
44.

Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil.

Sa-Filho D, Kallas EG, Sanabani S, Sabino E, Sucupira MC, Sanchez-Rosa AC, Tescarollo G, Tomiyama H, Bassichetto K, Janini LM, Diaz RS.

AIDS Res Hum Retroviruses. 2007 Sep;23(9):1087-94. No abstract available.

PMID:
17919103
45.

Quality assurance program for peripheral blood mononuclear cell cryopreservation.

Weinberg A, Louzao R, Mussi-Pinhata MM, Cruz ML, Pinto JA, Huff MF, de Castro AC, Sucupira MC, Denny TN.

Clin Vaccine Immunol. 2007 Sep;14(9):1242-4. Epub 2007 Jul 25.

46.

High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil.

Sucupira MC, Caseiro MM, Alves K, Tescarollo G, Janini LM, Sabino EC, Castelo A, Page-Shafer K, Diaz RS.

AIDS Patient Care STDS. 2007 Feb;21(2):116-28.

PMID:
17328661
47.

Less sensitive HIV-1 enzyme immunoassay as an adjuvant method for monitoring patients receiving antiretroviral therapy.

Cimerman S, Sucupira MC, Lewi DS, Diaz RS.

AIDS Patient Care STDS. 2007 Feb;21(2):100-5.

PMID:
17328659
48.

Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption.

Silva WP, Santos DE, Leal E, Brunstein A, Sucupira MC, Sabino EC, Diaz RS.

Virology. 2006 Oct 10;354(1):35-47. Epub 2006 Jul 25.

49.

Identification of two HIV type 1 circulating recombinant forms in Brazil.

De Sá Filho DJ, Sucupira MC, Caseiro MM, Sabino EC, Diaz RS, Janini LM.

AIDS Res Hum Retroviruses. 2006 Jan;22(1):1-13. Erratum in: AIDS Res Hum Retroviruses. 2006 Aug;22(8):824. Casiero, Marcos M [corrected to Caseiro, Marcos M].

PMID:
16438639
50.

Establishment of the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion (STARHS) strategy in the city of São Paulo, Brazil.

Kallas EG, Bassichetto KC, Oliveira SM, Goldenberg I, Bortoloto R, Moreno DM, Kanashiro C, Chaves MM, Sucupira MC, Diniz A, Mesquita FC.

Braz J Infect Dis. 2004 Dec;8(6):399-406. Epub 2005 May 9.

PMID:
15880230

Supplemental Content

Loading ...
Support Center